Indian authorities claim that Remdesivir is not a life-saving drug and it's unnecessary use is unethical.
In addition to that, the unavailability of vaccines to the younger generation may also be one of the leading factors as to why younger and healthy people are landing up in hospitals.Remdesivir is a patented antiviral drug manufactured by Gilead (US), initially developed for the treatment of viral hepatitis, and a cold-like virus called respiratory syncytial virus (RSV).
"Remdesivir is no magic bullet"
“The anti-viral drug must only be given to people who are hospitalised, have a fall in oxygen saturation and have infiltrates on the chest X-ray or CT-scan," Dr. Randeep Guleria, the director of the All India Institute of Medical Sciences (AIIMS) Delhi said on Monday, Times of India.
As per a Solidarity clinical trial by the World Health Organization (WHO), that looked into the effectiveness of Remdesivir against COVID-19, it was found that Remdesivir could not prevent COVID-19 related deaths.